/

Page 36 - U.S. Growth Pharmaceuticals & Biotech Stocks

UPDATED Apr 24, 2024

Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

845 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

INM

InMed Pharmaceuticals		US$0.301.0%-74.8%US$1.7mn/aPB0.1xS15.7%n/a

NTRB

Nutriband		US$3.85-9.8%6.9%US$30.1mn/aPS15.6xn/an/a

VNDA

Vanda Pharmaceuticals		US$4.56-13.0%-27.5%US$266.4mn/aPE104.6xn/an/a

CHRO

Chromocell Therapeutics		US$1.57-21.1%n/aUS$9.2mn/aPE-1.3xn/an/a

SXTC

China SXT Pharmaceuticals		US$1.07-9.3%-78.3%US$778.8kn/aPB0.2xn/an/a
Page 36 of 36
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.